VUTURO, Onofrio
VUTURO, Onofrio
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica
2005-01-01 SORESI M; FLORENA AM; CAMPAGNA P; DI GESARO V; GIAMBRA D; VUTURO O; CORSALE S; GIANNITRAPANI L
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis.
2006-01-01 SORESI, M; TRIPI, S; FRANCO, V; GIANNITRAPANI, L; ALESSANDRI, A; RAPPA, A; VUTURO, O; MONTALTO, G
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
2006-01-01 SORESI M; TRIPI S; FRANCO V; GIANNITRAPANI L; ALESSANDRI A; RAPPA F; VUTURO O; MONTALTO G
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons
2003-01-01 Tripi, S.; Soresi, M.; Di Gaetano, G.; Carroccio, A.; Giannitrapani, L.; Vuturo, O.; DI GIOVANNI, G.; Montalto, G.
Randomised trial of two different daily doses of interferon-α versus classical therapy in treatment-naïve patients with chronic hepatitis C
2002-01-01 Montalto, G.; Tripi, S.; Vuturo, O.; Di Gaetano, G.; Soresi, M.; Spadaro, A.; Aiello, A.; Russello, M.; Benigno, R.; Siciliano, R.
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C.
2007-01-01 GIANNITRAPANI L; SORESI M; INGRAO S; LA SPADA E; VUTURO O; FLORENA AM; CERVELLO M; MONTALTO G
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C
2005-01-01 S TRIPI; G DI GAETANO; A ALESSANDRI; O VUTURO; M SORESI; A SPADARO; M FRENI; S BRUNO; R SICILIANO; MONTALTO G
Viral clearance in HCV viraemic patients with normal aminotransferase after combination therapy: a controlled, open-labelled study
2004-01-01 MANGIA A; SPINZI G; VUTURO O; PAZIENZA V; IACOBELLIS A; PIATTELLI M; GIACOBBE A; LEANDRO G; PIERMANNI V; MINOLI G; MONTALTO G; ANDRIULLI A